The glutaminase inhibitor CB-839 (Telaglenastat) enhances the anti-melanoma activity of T cell mediated immunotherapies
| Image |  |
|---|---|
| Description | scientific article published on 23 December 2020 |
| Author/s |
author: Philip L Lorenzi Yared Hailemichael Jennifer L McQuade Leila J Williams Y N Vashisht Gopal Courtney Hudgens Weiyi Peng Jason Roszik Hannah R Hodges Sruthy Varghese |
| Publication date | December 23, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |